Evidence map›Paper›PMID 35705252›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2022

Realization of the T Lineage Program Involves GATA-3 Induction of Bcl11b and Repression of Cdkn2b Expression.

Patrycja K Thompson, Edward L Y Chen, Renée F de Pooter, Catherine Frelin, Walter K Vogel, Christina R Lee, Thomas Venables, Divya K Shah, Norman N Iscove, Mark Leid and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. T Cell Development: From T-Lineage Specification to Intrathymic Maturation.Advances in experimental medicine and biology · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Patrycja K ThompsonDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.
Edward L Y ChenDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0001-7197-2243
Renée F de PooterDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.
Catherine FrelinPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario.
Walter K VogelDepartment of Pharmaceutical Sciences, Oregon State University, Corvallis, OR; and.ORCID 0000-0002-5663-6660
Christina R LeeSunnybrook Research Institute, Toronto, Ontario, Canada.
Thomas VenablesThe Scripps-Florida Research Institute, Jupiter, FL.
Divya K ShahDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.
Norman N IscoveDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.
Mark LeidDepartment of Pharmaceutical Sciences, Oregon State University, Corvallis, OR; and.ORCID 0000-0002-2906-6703
Michele K AndersonDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-8820-5910
Juan Carlos Zúñiga-PflückerDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada; jczp@sri.utoronto.ca.ORCID 0000-0003-2538-3178
Sunnybrook Health Science Centre · CAOregon State University · USUniversity Health Network · CAScripps Research Institute · US

Funding

The role of TCR, ligand, and signal strength in human γδ T cell developmentP01AI102853 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI CORNELIS MURRE · 2014 to 2026
$26.3M
CIHR FDN-154332CIHR MOP-119538NIAID NIH HHS P01 AI102853
6 · The paper itself

Abstract

The zinc-finger transcription factor GATA-3 plays a crucial role during early T cell development and also dictates later T cell differentiation outcomes. However, its role and collaboration with the Notch signaling pathway in the induction of T lineage specification and commitment have not been fully elucidated. We show that GATA-3 deficiency in mouse hematopoietic progenitors results in an early block in T cell development despite the presence of Notch signals, with a failure to upregulate Bcl11b expression, leading to a diversion along a myeloid, but not a B cell, lineage fate. GATA-3 deficiency in the presence of Notch signaling results in the apoptosis of early T lineage cells, as seen with inhibition of CDK4/6 (cyclin-dependent kinases 4 and 6) function, and dysregulated cyclin-dependent kinase inhibitor 2b (Cdkn2b) expression. We also show that GATA-3 induces Bcl11b, and together with Bcl11b represses Cdkn2b expression; however, loss of Cdkn2b failed to rescue the developmental block of GATA-3-deficient T cell progenitor. Our findings provide a signaling and transcriptional network by which the T lineage program in response to Notch signals is realized.

Indexed as

Signal TransductionT-LymphocytesAnimalsCell DifferentiationCell LineageCyclin-Dependent Kinase Inhibitor ProteinsGATA3 Transcription FactorGene Regulatory NetworksMiceRepressor ProteinsTumor Suppressor ProteinsBcl11b protein, mouseCyclin-Dependent Kinase Inhibitor ProteinsGata3 protein, mouseGATA3 Transcription FactorRepressor ProteinsTumor Suppressor Proteins

Identifiers

PMID35705252
PMCPMC9248976
OpenAlexW4283014977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.